Clinical Trial Update: Hepatocyte Growth Factor and Cardiovascular Autonomic Function

View source ↗

Summary

A completed clinical trial evaluated the effects of hepatocyte growth factor on cardiovascular autonomic function in individuals with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Hepatocyte Growth Factor (hepatocyte growth factor)

Snippet

Sponsor: Oita Red Cross Hospital | Conditions: Type-2 Diabetes | Status: COMPLETED